AVIR Atea Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AVIR

Price (delayed)

$5.07

Market cap

$406.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.08

Enterprise value

$330.51M

?
Relative Growth: Rel. Growth: 5
Relative Strength: Rel. Strength: 77
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 5
Highlights
The debt has dropped by 66% year-on-year and by 33% since the previous quarter
Atea Pharmaceuticals's net income has decreased by 21% YoY but it has increased by 2.5% from the previous quarter
Atea Pharmaceuticals's quick ratio has shrunk by 59% YoY
The company's equity fell by 44% YoY and by 13% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.ateapharma.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of AVIR

AVIR stock price

How has the Atea Pharmaceuticals stock price performed over time
Intraday
0.2%
1 week
1.6%
1 month
6.96%
1 year
44.86%
YTD
42.02%
QTD
9.03%

Financial performance

How have Atea Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$183.61M
Net income
-$165.29M
Gross margin
N/A
Net margin
N/A
Atea Pharmaceuticals's net income has decreased by 21% YoY but it has increased by 2.5% from the previous quarter
The operating income is down by 17% YoY but it is up by 3.3% QoQ

Price vs fundamentals

How does AVIR's price correlate with its fundamentals

Growth

What is Atea Pharmaceuticals's growth rate over time

Valuation

What is Atea Pharmaceuticals stock price valuation
P/E
N/A
P/B
1.99
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Atea Pharmaceuticals's EPS has decreased by 29% YoY
AVIR's P/B is 99% higher than its 5-year quarterly average of 1.0 and 53% higher than its last 4 quarters average of 1.3
The company's equity fell by 44% YoY and by 13% QoQ

Efficiency

How efficient is Atea Pharmaceuticals business performance
AVIR's return on invested capital has dropped by 139% year-on-year and by 19% since the previous quarter
The company's return on equity has shrunk by 98% YoY and by 13% QoQ
The ROA has shrunk by 87% YoY and by 11% QoQ

Dividends

What is AVIR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVIR.

Financial health

How did Atea Pharmaceuticals financials performed over time
Atea Pharmaceuticals's quick ratio has shrunk by 59% YoY
The current ratio has dropped by 58% year-on-year but it rose by 3% since the previous quarter
The debt is 100% smaller than the equity
The debt has dropped by 66% year-on-year and by 33% since the previous quarter
The company's equity fell by 44% YoY and by 13% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.